OTHER INFORMATION
+Added: During the three months ended March 31, 2025, no director or officer, as defined in Rule 16a - 1 (f) under the Securities Exchange Act of 1934, as amended, of the Company adopted or terminated a "Rule 10b5 - 1 trading arrangement" or "non-Rule 10b5 - 1 trading arrangement," as each term is defined in Item 408 (a) of Regulation S-K.
Incorporated by Reference
7 unchanged sentences
Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant (filed 07/11/2024, effective 07/15/2024)
+Added: Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant (effective 1/13/2025)
Certificate of Designation of Series X Convertible Preferred Stock.
Certificate of Designation of Series A Preferred Stock.
+Added: Certificate of Designation of Series B Preferred Stock.
Amended and Restated Bylaws of the Registrant.
7 unchanged sentences
Form of placement agent warrant offered in July 2020.
+Added: Form of placement agent warrant offered in October 2024
Form of Series B Warrant offered in February 2022.
+Added: Form of Series C Warrant issued in July 2022
Warrant Agency Agreement, dated February 8, 2022, by and between the Registrant and American Stock & Trust Company LLC.
10 unchanged sentences
Form of Placement Agent Warrant
−Removed: First Amendment to 8% Short Term Promissory Notes Payable to FatBoy Capital, L.P.
−Removed: First Amendment to 8% Short Term Promissory Note Payable to David A.
−Removed: First Amendment to 8% Short Term Promissory Note Payable to Jenkins Family Charitable Institute
−Removed: Warrant Agency Agreement dated September 3, 2024, by and between Catheter Precision, Inc.
−Removed: and Equiniti Trust Company, LLC
−Removed: Investment Banking Agreement dated May 9, 2024
+Added: Form of Underwriters' Warrant offered in September 2024
+Added: Form of Warrant Agency Agreement dated as of September 3, 2024 entered into by and between the Registrant and Equiniti Trust Company, LLC
+Added: Form of Series L Warrant offered in May 2025.
+Added: Non-plan Stock Option Award granted January 6, 2025 to Philip Anderson
+Added: Offer Letter to Philip Anderson dated January 3, 2025
Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
−Removed: Certifications of Principal Executive Officer pursuant to 18 U.S.C.
+Added: Certification of Principal Executive Officer pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: Certifications of Principal Financial Officer pursuant to 18 U.S.C.
+Added: Certification of Principal Financial Officer pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
11 unchanged sentences
CATHETER PRECISION, INC.
−Removed: November 13, 2024
Executive Chairman of the Board and
1 unchanged sentence
(Principal Executive Officer)
−Removed: November 13, 2024
−Removed: /s/ Margrit Thomassen
−Removed: Margrit Thomassen
−Removed: Interim Chief Financial Officer
+Added: /s/ Philip Anderson
+Added: Philip Anderson
+Added: Chief Financial Officer
(Principal Financial and Accounting Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.